Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism

World Journal of Surgery

Volumn 27, Issue 4, 2003, Pages 481-485

  Bergenfelz, Anders ^a   Lindblom, Pia ^a   Lindergård, Birger ^a   Valdemarsson, Stig ^a   Westerdahl, Johan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM ION; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PREOPERATIVE EVALUATION;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PREOPERATIVE CARE; SEVERITY OF ILLNESS INDEX;

EID: 0042744773     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6649-1     Document Type: Article

References (25)

1. Heath H, 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity and potential economic impact in a community. N. Engl. J. Med. 1980;302:189-193
2. Palmér M, Ljunghall S, Åkerström G, et al. Patients with hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. J. Chron Dis. 1987;40:121-130
3. Siperstein AE, Shen W, Chan AK, et al. Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch. Surg. 1992;127:1157-1160
4. Lundgren W, Rastad J, Thurfjell E, et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287-294
5. Bergenfelz A, Valdemarsson S, Ahrén B. Measurement of intact parathyroid hormone in the diagnosis of hyperparathyroidism. Acta Endocrinol. (Copenh.) 1991;125:668-674
6. Mischis-Troussard C, Goudet P, Verges B, et al. Primary hyperparathyroidism with normal serum intact parathyroid hormone. Q. J. Med. 2000;93:365-367
7. Rastad J, Ridefelt P. Parathyroid hormone: regulation of secretion and laboratory determination. In Clark OH, Duh QY, editors, Textbook of Endocrine Surgery. Philadelphia, W. B. Saunders Company, 1997;284-295
8. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann. Intern. Med. 1991;114:593-597
9. Westerdahl J, Lindblom P, Valdemarsson S, et al. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch. Surg. 2000;135:142-147
10. Grimelius L, Åkerström G, Bondesson L, et al. The role of the pathologist in the diagnosis and surgical decision making in hyperparathyroidism. World J. Surg. 1991;15:698-705
11. Bergenfelz A, Isaksson A, Ahrén B. Intra-operative monitoring of intact PTH during surgery for primary hyperparathyroidism. Langenbecks Arch. Chir. 1994;379:50-53
12. Becker W. (in Swedish): Svenskarna äter nyttigare - allt fler väljer grönt. Vår Föda. 1999;24:24-27
13. Krutzén E, Bäck SE, Nilsson-Ehle I, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med. 1984;104:955-961
14. Bäck SE, Ljungberg B, Nilsson-Ehle I, et al. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand. J. Clin. Lab. Invest. 1989;49:641-646
15. Lindergård B. Bone mineral content measured by photon absorptiometry - a methodological study carried out in normal individuals. Scand. J. Urol. Nephrol. 1981;59(suppl):1-37
16. Joborn C, Hetta J, Johansson H, et al. Psychiatric morbidity in primary hyperparathyroidism. World J. Surg. 1988;12:476-481
17. Lundgren E, Ljunghall S, Åkerström G, et al. Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. Surgery 1998;124:980-985
18. Harrison BJ, Wheeler MH. Asymptomatic primary hyperparathyroidism. World J. Surg. 1991;15:724-729
19. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with and without parathyroid surgery. N. Engl. J. Med. 1999;341:1249-1255
20. Hedbäck G, Odén A, Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J. Surg. 1991;15:399-405
21. Westerdahl J, Valdemarsson S, Lindblom P, et al. Urate and arteriosclerosis in primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 2001;54:805-811
22. Luts L, Bergenfelz A, Alumets J, et al. Parathyroid function and histology in patients with parathyroid adenoma: correlation of clinical and morphological findings. World J. Surg. 1997;21:553-563
23. Loda M, Lipman J, Cukor B, et al. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum. Pathol. 1994;25:1050-1056
24. Arnold A, Staunton CE, Kim GH, et al. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N. Engl. J. Med. 1988;318:658-662
25. Williams JG, Wheeler MH, Aston JP, et al. The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism. Am. J. Surg. 1992;163:301-304